FDA Approves Potentially Groundbreaking Schizophrenia Drug
People living with schizophrenia will soon have a new and potentially groundbreaking treatment available. With its approval, theres new hope for better managing this challenging condition. This drug takes the first new approach to schizophrenia treatment in decades. © Bristol Myers Squibb In the large-scaleclinical trialsreviewed by the FDA, Cobenfy appeared to work as intended. Compared to placebo, people on Cobenfy saw a significant improvement in their schizophrenia symptoms. But the simple virtue of being the first in a novel drug class cant be overstated....